Heterogeneous Increase in CD34-positive Alveolar Capillaries in Idiopathic Pulmonary Fibrosis
Masahito Ebina(Tohoku University), Toshihiro Nukiwa(Tohoku University), Minoru Shimizukawa(Tohoku University), Takashi Suzuki(Tohoku University), Yuichiro Kimura(Tohoku University), Takashi Kondo(University of Toyama), Naoko Shibata(Tohoku University), Mareyuki Endo(Tohoku University), Hironobu Sasano(Tohoku University)
American Journal of Respiratory and Critical Care Medicine
February 2, 2004
Cited by 320
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953